Lung Cancer Clinical Trials in Rochester, New York

5 studies are recruiting for lung cancer in Rochester, New York right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma

   Study QXL138AM-001 is a Phase 1a/1b study to investigate the safety, pharmacokinetics, and preliminary activity of QXL138AM in subjects with locally advanced un-resectable and/or metastatic solid tumors and multiple myeloma. The study is an open-label, multicenter, first in human study to be conduc…

   Stage

   Phase 1

   Ages

   18 and older

   Site

   University of Rochester - Wilmot Cancer Institute, Rochester, New York

   Locations

   10 in total

   Run by

   Nammi Therapeutics Inc

   See if you can join NCT06582017 on ClinicalTrials.gov

2. Cardiopulmonary Monitoring in Lung Cancer Patients Receiving Combined Thoracic Radiotherapy and Immunotherapy

   The overall purpose of this study is to evaluate cardiopulmonary toxicity in patients with lung cancer (NSCLC or SCLC) undergoing combined thoracic radiotherapy ± chemotherapy and immunotherapy through timed monitoring and blood sample collection and to identify correlative biomarkers for predictin…

   Stage

   Not phased

   Ages

   18 and older

   Site

   University of Rochester Medical Center, Rochester, New York

   Locations

   3 in total

   Run by

   Bo Lu

   See if you can join NCT06410300 on ClinicalTrials.gov

3. Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer

   This study's goal is to find out if the kind of side effects people experience from radiation is different depending on the schedule of their radiation treatment. Patients will be randomly assigned to either the 3 Fraction or 5 Fraction schedule of radiation. After patients complete radiation treat…

   Stage

   Not phased

   Ages

   18 and older

   Site

   James P. Wilmot Cancer Center at University of Rochester Medical Center, Rochester, New York

   Run by

   University of Rochester

   See if you can join NCT03706027 on ClinicalTrials.gov

4. Increasing Lung Cancer Screening Uptake Among Emergency Department Patients

   The objective of the proposed clinical trial is to determine if we can increase LCS among ED patients using a combination of facilitated referral to an LCS program plus text message reminders to get screened. Step 1 of the approach is to identify participants that are eligible for LCS. Step 2 is to…

   Stage

   Not phased

   Ages

   50 to 80

   Site

   University of Rochester, Rochester, New York

   Run by

   University of Rochester

   See if you can join NCT07287085 on ClinicalTrials.gov

5. Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

   The goal of this observational study is to learn how a physician uses the results of the Percepta® Nasal Swab test to manage people with a newly identified pulmonary nodule. The main questions it aims to answer are: * Does the use of the Percepta Nasal swab test reduce the number of invasive proced…

   Stage

   Not phased

   Ages

   29 to 85

   Site

   University of Rochester Medical Center, Rochester, New York

   Locations

   23 in total

   Run by

   Veracyte, Inc.

   See if you can join NCT06426628 on ClinicalTrials.gov